Search Details

Word: marketing (lookup in dictionary) (lookup stats)
Dates: during 2000-2009
Sort By: most recent first (reverse)


Usage:

There are no kids in Hollywood, only a kid market. So the moguls gleefully rub their rough hands at the recent blooming of animated features into a reliable blockbuster genre. Anyone could have predicted that Pixar's Up, Blue Sky's Ice Age 3 and DreamWorks' Monsters vs Aliens would be among the year's top-grossing pictures, but who saw Cloudy With a Chance of Meatballs coming? The success of Meatballs, G-Force and Where the Wild Things Are underlines the movie industry's hope that in every jaded teen or wizened adult there's an inner child whose...

Author: /time Magazine | Title: Astro Boy: Sweet Sci-Fi for Your Inner Child | 10/23/2009 | See Source »

...addiction to oil. Nine billion gallons of corn ethanol were produced in the U.S. in 2008, while countries like Brazil have already widely replaced gasoline with ethanol from sugar cane and countless start-ups are working to bring cellulosic and other second-generation biofuels to market. The reasoning is that if we use greener biofuels in place of gasoline, it will significantly enhance our effort to reduce greenhouse-gas emissions...

Author: /time Magazine | Title: Tallying Biofuels' Real Environmental Cost | 10/23/2009 | See Source »

...ways to control health-care costs, the price of biologics is drawing more and more scrutiny. The obvious model for bringing in competition is a 1984 law that Waxman wrote with Republican Senator Orrin Hatch. It lowered the regulatory obstacles that prevented generic drugs from making their way to market. At the time, it was expected that fast-tracking the approval of "bioequivalent" drugs would bring down medical costs by $1 billion a year. But with generics now accounting for more than 70% of prescriptions dispensed in the U.S., "the actual savings have exceeded our wildest expectations," Waxman said...

Author: /time Magazine | Title: How Drug-Industry Lobbyists Won on Health-Care | 10/22/2009 | See Source »

...resolved - in favor of protecting the biotech industry or opening up the market to generics - may say a lot about which interest groups will ultimately reap the windfall of the big-stakes battle in Washington. What it means for consumers is somewhat murkier: Will a miracle cure be there when you need one? And if it is, will you be able to afford it? Those are questions that hinge on whether the rest of us can trust Congress to find proper balance between competition and innovation...

Author: /time Magazine | Title: How Drug-Industry Lobbyists Won on Health-Care | 10/22/2009 | See Source »

...stronger-than-expected rate hikes," wrote Jun Ma, an economist at Deutsche Bank in Hong Kong, in a September note. Concerns are also mounting that continued loose monetary policy in Asia could fuel dangerous and unstable asset price bubbles, especially in property. There has been some speculation in financial markets that South Korea's central bank could raise interest rates in the coming months to cool a roaring housing market. Frederic Neumann, an economist at HSBC in Hong Kong, says Asian central bankers might need to hike rates by four percentage points over the next year - much more than...

Author: /time Magazine | Title: Can the World Agree on a Stimulus Exit Plan? | 10/22/2009 | See Source »

Previous | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | Next